Dr. Lawrence B. Colen, MD

Dr. Colen practices at Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health.

Dr. Colen's NPI, 1255442174, was assigned on August 31, 2006. Dr. Colen graduated from Geisel School Of Medicine At Dartmouth in 1975. Dr. Colen holds Virginia license 0101044977.

Dr. Colen's primary practice is Sentara Norfolk General Hospital, at 600 Gresham Dr, Norfolk, VA 23507 in Norfolk City. The practice phone is (757) 388-3000.

Dr. Colen's primary practice is Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health. Dr. Colen is also affiliated with Sentara Leigh Hospital. The medical group on file is Norfolk Plastic Surgery, P.C. Dmand AI also links Dr. Colen to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colen practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Colen's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Colen is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Colen's licenses on file in 3 states: Virginia, New Hampshire and California.

Dmand AI lists breast surgery, cancerous skin growth removal, lymphedema and removal of damaged skin or skin graft among the conditions Dr. Colen treats.

CMS data shows 242 Medicare services from Dr. Colen across 4 procedure codes in 2024, for 124 Medicare patients. Medicare paid $20,191 for them. Every service was in an office.

CMS counts 124 Medicare patients who saw Dr. Colen in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Colen's median patient age at 62, with 82% women.

In 2024, Dr. Colen wrote 131 Medicare Part D claims for 46 patients. 95% of them were for generic drugs. CMS names the drug for 57 of them, across 3 drugs with 11 or more claims each, at $160 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

Dr. Colen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 53 procedures of melanoma (skin cancer) excision by Dr. Colen, more than 87% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 64 papers to Dr. Colen in 2017. The most frequent topics are Surgical Flaps, Microsurgery and Leg. Dr. Colen has published most often in Plast Reconstr Surg. Dr. Colen's most frequent co-authors are Rocco Raffaele Addante, DMD, MD, Christopher Ernst Attinger and Suzanne Bruce, MD.

CMS Open Payments shows 170 general payments to Dr. Colen from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Allergan Inc. paid the most, $4,308.

Dmand AI lists 14 awards for Dr. Colen, most recently Director in 2014.

Dr. Colen graduated from Geisel School Of Medicine At Dartmouth in 1975. Dr. Colen is a member of ACS and ASPS.

Dr. Colen is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Molina. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.